Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
M Valenciano (
)<SUP>1</SUP><SUP>,2</SUP>, E Kissling<SUP>1</SUP><SUP>,2</SUP>, I-MOVE case?control study team<SUP>3</SUP>
Citation style for this article: Valenciano M, Kissling E, I-MOVE case?control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case?control study, 2012/13 . Euro Surveill. 2013;18(7)
ii=20400. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20400
Date of submission: 08 February 2013 <HR>We conducted a test-negative case?control study based in five European sentinel surveillance networks. The early 2012/13 adjusted influenza vaccine effectiveness was 78.2% (95% CI: 18.0 to 94.2) against influenza B, 62.1% (95% CI: −22.9 to 88.3%) against A(H1)pdm09, 41.9 (95% CI: −67.1 to 79.8) against A(H3N2) and 50.4% (95% CI: −20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications.
- ------
Eurosurveillance, Volume 18, Issue 7, 14 February 2013
Rapid communications
Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case?control study, 2012/13
Rapid communications
Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case?control study, 2012/13
M Valenciano (
- EpiConcept, Paris, France
- These authors contributed equally to the work and share first authorship
- Members of the team are listed at the end of the article
Citation style for this article: Valenciano M, Kissling E, I-MOVE case?control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case?control study, 2012/13 . Euro Surveill. 2013;18(7)
ii=20400. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20400 Date of submission: 08 February 2013 <HR>We conducted a test-negative case?control study based in five European sentinel surveillance networks. The early 2012/13 adjusted influenza vaccine effectiveness was 78.2% (95% CI: 18.0 to 94.2) against influenza B, 62.1% (95% CI: −22.9 to 88.3%) against A(H1)pdm09, 41.9 (95% CI: −67.1 to 79.8) against A(H3N2) and 50.4% (95% CI: −20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications.